Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
30 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Titan Pharmaceuticals, Inc. (Titan) is a biopharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. The company product portfolio offers probuphine for the treatment of opioid addiction, repinirole implant for treating Parkinson's disease and T3 implant for the treatment of hypothyroidism.

Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

  
Source:
Document ID
GDPH81661D
Country
Industry
Ticker
TTNP=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Titan Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Titan Pharmaceuticals, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Titan Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Titan Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Titan Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 201691
Titan Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Titan Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deal Details1116
  Licensing Agreements111
    Braeburn Pharma Exercises Option For Licensing Agreement With Titan Pharma For Probuphine112
    Titan Pharma Amends Licensing Agreement with Braeburn Pharma for Probuphine132
  Equity Offering151
    Titan Pharma Raises USD10.5 Million in Public Offering of Units152
    Titan Pharma Raises USD5 Million in Private Placement of Shares171
    Titan Pharma Raises USD1.3 Million in Private Placement of Shares upon Exercise of Series A Warrants181
    Titan Pharma Raises USD4 Million in Private Placement of Shares upon Exercise of Series B Warrants191
    Titan Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Series B Warrants201
    Titan Pharma Completes Private Placement Of Shares For US$4 Million211
    Titan Pharma Announces Private Placement Of Shares For US$5.5 Million221
    Titan Pharma Plans Rights Offering Of Common Stock231
    Titan Pharma Files Registration Statement For Public Offering Of Securities For US$25 Million241
  Asset Transactions251
    Titan Pharma Sells Royalty Stream Of Fanapt To Deerfield Management For US$15 Million252
Titan Pharmaceuticals, Inc. - Key Competitors271
Key Employees281
Locations And Subsidiaries291
  Head Office291
Appendix301
  Methodology301
  About GlobalData301
  Contact Us301
  Disclaimer301

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Titan-Pharmaceuticals-Inc-TTNP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7713>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Titan-Pharmaceuticals-Inc-TTNP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7713>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research